The combination of NfL with both clinical markers did however result in a higher AUC for distinguishing PD progression phenotypes in comparison to NFL alone (0.79 vs 0.85, p=0.0163) (online supplemental table 4). The gene discussed is NEFL; the disease is Parkinson disease.